RenovoRx
RNXT
28 hedge funds and large institutions have $9M invested in RenovoRx in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
5% more capital invested
Capital invested by funds: $8.58M → $9M (+$419K)
2.97% less ownership
Funds ownership: 23.37% → 20.39% (-3%)
10% less funds holding
Funds holding: 31 → 28 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$636K |
| 2 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$74.9K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$39.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.6K |
| 5 |
CCFM
Clear Creek Financial Management
Silverdale,
Washington
|
+$26.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPT
Nixon Peabody Trust
Boston,
Massachusetts
|
-$98.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$90.1K |
| 3 |
HF
HRT Financial
New York
|
-$43K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$22.6K |
| 5 |
CPWM
Cypress Point Wealth Management
Dallas,
Texas
|
-$20.2K |
RNXT Hedge Fund Activity: Q2 2026 in Review
28 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q2 2026, worth a combined $9M — up 4.9% from $8.58M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RNXT and 3 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was AIGH Capital Management, adding an estimated $636K. The largest seller was Nixon Peabody Trust, exiting entirely with an estimated $98.1K sold.
- 28 institutional investors held RenovoRx (RNXT) as of Q2 2026, down from 31 in Q1 2026.
- Funds reported $9M of RenovoRx stock for Q2 2026, up 4.9% quarter-over-quarter.
- 3 funds opened new RenovoRx positions in Q2 2026 and 6 closed out, a net change of -3 holders.
- The largest RenovoRx buyer in Q2 2026 was AIGH Capital Management, an estimated $636K added.
- The largest RenovoRx seller in Q2 2026 was Nixon Peabody Trust, an estimated $98.1K sold.
Based on aggregated 13F filings for Q2 2026.